Imaging Inflammation in Compensated Advanced Chronic liver disease as a new predictor for liver decompensation
DOI: 10.54647/cm321260 41 Downloads 4045 Views
Author(s)
Abstract
Introduction: Alcohol and Non-alcoholic fatty liver disease (NAFLD) are the commonest causes of advanced chronic liver disease (ACLD) worldwide. Various imaging are commonly used in the diagnosis and follow up of these patients. Child Pugh and Model of end stage liver disease systems are used for survival and three mortality of decompensated ACLD patients. However there is a need for imaging biomarkers for compensated ACLD (cACLD) patients to predict likelihood of decompensation. With increasing stress on the role of systemic inflammation as a causative agent in the progression and decompensation of ACLD patients the new imaging technique of shear wave elastography with dispersion of liver (SWD) and small bowel (SBD) were evaluated alongwith liver stiffness estimation.
Material and Methods: 61 patients with cACLD with NAFLD or history of alcohol ingestion were enrolled after informed consent and were followed for a period of three months for any decompensation i.e. ascites, gastrointestinal bleed or encephalopathy. All patients underwent a fasting ultrasound examination with shear wave elastography and liver stiffness alongwith shear wave dispersion (SWD) and small bowel inflammation (SBD). Follow up examinations were done at 30, 45 and 90 days or any time in between if there was any clinical evidence of decompensation. The patients were divided into four groups I-IV based on SWD and SBD findings as group I(A0B1),group II(A1B0), group , Group III(A1B1), group (A0B0). Statistical analysis was done to assess the significance of differences in the groups and incidence of decompensation recorded in each group. A prediction model was developed using machine learning based on above parameters to predict decompensation in a 90 day period.
Results: Group II and III performed the largest groups with 44 patients. Statistically significant differences were seen in SWD and SBD in all the groups (p<0.001). A good linear regression of 0.52 and 0.64 was seen between SWD and SBD and liver stiffness. The study showed decompensation in 12/61 patients the largest were number being in the groups III and II with decompensation likelihood of 27% and 24% respectively using Kaplan Meyer survival plot.SBD showing a highest hazard ratio of 1:24.4 while SWD alone had hazard ratio of 1:2.4.
Conclusion: The use of SWE markers is a novel way to evaluate patients with cACLD patients and using machine learning model predict 3 month likelihood of decompensation with 75% accuracy.
Keywords
Compensated advanced chronic liver disease, Cirrhosis, shear wave elastography, Shear wave dispersion, decompensated advanced liver disease.
Cite this paper
Atul Kapoor, Aprajita kapur,
Imaging Inflammation in Compensated Advanced Chronic liver disease as a new predictor for liver decompensation
, SCIREA Journal of Clinical Medicine.
Volume 9, Issue 2, April 2024 | PP. 50-69.
10.54647/cm321260
References
[ 1 ] | Mas VR, Fassnacht R, Archer KJ, Maluf D. Molecular mechanisms involved in the interaction effects of alcohol and hepatitis C virus in liver cirrhosis. Mol Med 2010; 16: 287-297 [PMID: 20386865 DOI: 10.2119/molmed.2009.00165]. |
[ 2 ] | Weiskirchen R, Tacke F. Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg Nutr 2014; 3: 344-363 [PMID: 25568859 DOI: 10.3978/j.issn.2304-3881.2014.11.03. |
[ 3 ] | Asrani SK, Kamath PS. Natural history of cirrhosis. Curr Gastroenterol Rep 2013; 15: 308 [PMID: 23314828 DOI: 10.1007/s11894-012-0308-y |
[ 4 ] | Albillos A, Lario M, Álvarez-Mon M. Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance. J Hepatol 2014; 61: 1385-1396 [PMID: 25135860 DOI: 10.1016/j.jhep.2014.08.010]. |
[ 5 ] | Arroyo V, García-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol 2014; 61: 396-407 [PMID: 24751830 DOI: 10.1016/j.jhep.2014.04.012]. |
[ 6 ] | Sugimoto, K.; Moriyasu, F.; Oshiro, H.; Takeuchi, H.; Yoshimasu, Y.; Kasai, Y.; Itoi, T. Clinical Utilization of ShearWave Dispersion Imaging in Diffuse Liver Disease. Ultrasonography 2020, 39, 3–10. |
[ 7 ] | Jeong, J.Y.; Cho, Y.S.; Sohn, J.H. Role of Two-Dimensional Shear Wave Elastography in Chronic Liver Diseases: A Narrative Review. World J. Gastroenterol. 2018, 24, 3849–3860. |
[ 8 ] | Claria J, Stauber RE, Coenraad MJ, Moreau R, Jalan R, Pavesi M, et al. Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure. Hepatology 2016;64:1249–1264. |
[ 9 ] | Child C, Turcotte J. Surgery and portal hypertension. In: Child CG, ed. The Liver and Portal Hypertension. Philadelphia: Saunders, 1964:50. |
[ 10 ] | Christensen E, Schlichting P, Fauerholdt L, Gluud C, Anderson P, Juhl E, Poulson H, et al. Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. HEPATOLOGY 1984;4:430-435. |
[ 11 ] | Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. HEPATOLOGY 2000;31:864-871. |
[ 12 ] | Jeong, J.Y.; Cho, Y.S.; Sohn, J.H. Role of Two-Dimensional Shear Wave Elastography in Chronic Liver Diseases: A Narrative Review. World J. Gastroenterol. 2018, 24, 3849–3860 |
[ 13 ] | Sugimoto, K.; Moriyasu, F.; Oshiro, H.; Takeuchi, H.; Yoshimasu, Y.; Kasai, Y.; Itoi, T. Clinical Utilization of ShearWave Dispersion Imaging in Diffuse Liver Disease. Ultrasonography 2020, 39, 3–10 |
[ 14 ] | Giannelli V, Di Gregorio V, Iebba V, Giusto M, Schippa S, Merli M, Thalheimer U. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis. World J Gastroenterol 2014; 20: 16795-16810 [PMID: 25492994 DOI:10.3748/wjg.v20.i45.16795]. |
[ 15 ] | Kapoor A, Singh A, kapur A, Mahajan G, Sharma S. Use of shear wave imaging with intestinal ultrasonography in patients with chronic diarrhea. J of clinical ultrasound 2023; 1-13. https://doi.org/10.1002/jcu.23594 |
[ 16 ] | Shi Y, Yang Y, Hu Y, Wu W, Yang Q, Zheng M, Zhang S, Xu Z,Wu Y, Yan H, Chen Z. Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults. Hepatology 2015; 62: 232-242 [PMID: 25800029 DOI:10.1002/hep.27795] |
[ 17 ] | Tiegs G, Lohse AW. Immune tolerance: what is unique about the liver. J Autoimmun 2010; 34: 1-6 [PMID: 19717280 DOI: 10.1016/j.jaut.2009.08.008. |
[ 18 ] | Ilan Y. Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis. World J Gastroenterol 2012; 18:2609-2618 [PMID: 22690069 DOI: 10.3748/wjg.v18.i21.2609]. |
[ 19 ] | Lutz P, Nischalke HD, Strassburg CP, Spengler U. Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver. World J Hepatol 2015; 7: 304-314 [PMID:25848460 DOI: 10.4254/wjh.v7.i3.304]. |
[ 20 ] | Fukui H. Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia. World J Hepatol 2015; 7: 425-442 [PMID: 25848468 DOI: 10.4254/wjh.v7.i3.425]. |
[ 21 ] | Aoyama T, Paik YH, Seki E. Toll-like receptor signaling and liver fibrosis. Gastroenterol Res Pract 2010; 2010: pii: 192543 [PMID: 20706677 DOI: 10.1155/2010/192543] |
[ 22 ] | Nakamoto N, Kanai T. Role of toll-like receptors in immune activation and tolerance in the liver. Front Immunol 2014; 5: 221[PMID: 24904576 DOI: 10.3389/fimmu.2014.00221]. |
[ 23 ] | Ferraioli, G.; Maiocchi, L.; Dellafiore, C.; Tinelli, C.; Above, E.; Filice, C. Performance and Cutoffs for Liver Fibrosis Staging of aTwo-Dimensional Shear Wave Elastography Technique. Eur. J. Gastroenterol. Hepatol. 2021, 33, 89–95. |